Trump’s national security tariffs target semiconductors and pharmaceuticals amid supply chain shifts
- The Trump administration plans to impose tariffs on imported semiconductors, electronics and pharmaceuticals under Section 232 of the 1962 Trade Expansion Act, citing national security concerns and aiming to reduce U.S. reliance on foreign supply chains, particularly China.
- The move mirrors past Trump-era tariffs on steel and aluminum, with new 25% tariffs anticipated within months. The administration seeks domestic production of critical technologies, emphasizing non-negotiable trade policies.
- Democrats, led by Senator Elizabeth Warren, plan to curb presidential tariff authority, citing executive overreach, while markets react with volatility—stocks surged 9.5% after Trump delayed initial tariff plans.
- The administration defends tariffs as crucial for supply chain resilience, but critics warn of higher costs and tech supply disruptions. Final decisions will follow public comments (due May 7) and could reshape U.S. trade policy long-term.
U.S. President Donald Trump announced on April 13 that his administration will impose new tariffs on imported semiconductors and electronics within weeks, as part of a broader Section 232 national security investigation targeting the entire electronics and pharmaceutical supply chains. The move expands a trade strategy aimed at reducing U.S. reliance on foreign manufacturing, particularly from China, and follows similar actions under Trump’s first term. Commerce Secretary Howard Lutnick confirmed the tariffs would fall under the 1962 Trade Expansion Act, with semiconductor production, pharmaceuticals and related consumer goods now under scrutiny. The administration aims to secure domestic production of critical technologies but faces pushback from Democrats and market volatility.
The tariff strategy: Expanding under Section 232, a proven but contentious tool
The president’s plan builds on Section 232 of the Trade Expansion Act of 1962, which empowers the president to restrict imports deemed threats to national security. Under Trump, the law has been used twice before—imposing tariffs on steel and aluminum in 2018—citing similar concerns over foreign economic dominance. “We want to make our chips and semiconductors and other things in our country,” Trump stated on Air Force One. “And that’ll take place in the very near future.”
The semiconductor and pharmaceutical probes, initiated on April 1, will analyze supply chain vulnerabilities and the feasibility of domestic production. The Federal Register confirmed the scope includes not just raw chips but also manufacturing equipment and downstream products like smartphones, laptops and medical devices. Commerce Secretary Lutnick emphasized that exemptions from Trump’s earlier “reciprocal tariffs” on electronics were temporary. “They’re included in the semiconductor tariffs, which are coming in probably a month or two,” he told ABC News. The administration aims for a “non-negotiable” regime, with tariffs potentially set at 25%.
Supply chain context: A shift toward “onshoring” manufacturing
The push reflects longstanding concerns about U.S. dependency on foreign manufacturing. Over 85% of advanced semiconductors are produced in Taiwan, with finishing often done in China, creating strategic risks. The Biden administration’s CHIPS and Science Act of 2022 allocated $53 billion to bolster domestic semiconductor production, and President Trump now seeks to accelerate this. “We can’t be reliant on Southeast Asia for all the things that operate for us,” Lutnick said, citing the recent 3 billion Panasonic factory in Kansas as a shift toward high-tech U.S. jobs.
Taiwan Semiconductor Manufacturing Co. recently announced an additional $100 billion investment in U.S. chip plants, while NVIDIA plans domestic AI supercomputer factories. These moves align with Trump’s goals, though critics argue tariffs could disrupt global tech supply chains, inflating costs. The U.S. stock market surged 9.5% on April 9 after Trump paused his initial universal tariff plan for 90 days, reflecting investor anxiety over economic impacts.
Political and legislative pushback: Calls to limit executive power
While Republicans have generally supported Trump’s trade agenda, Democrats have intensified opposition. Senator Elizabeth Warren (D-Mass.) said her party will push legislation to curb presidential tariff authority. “Every Democrat is ready to go, to push back or take away from the president the power he’s now exercising,” Warren told ABC News on April 15. A vote within 15 days could set the stage for a broader congressional clash over executive overreach.
Meanwhile, the administration defends its actions as critical for national resilience. Senior counselor Peter Navarro highlighted the goal of “stability and resilience” in supply chains, stressing that securing domestic capacity for pharmaceuticals and semiconductors is “essential to safeguarding independence.” The Federal Register will accept public comments until May 7, with final tariff rules potentially announced this summer.
A calculated risk in the new trade landscape
President Trump’s aggressive tariff strategy underscores a recalibration of U.S. trade policy, prioritizing national security over global economic interdependence. By targeting semiconductors and pharmaceuticals—cornerstones of AI and healthcare—the administration aims to reshape manufacturing landscapes. Yet the plan’s success hinges on balancing protectionist goals with economic realities. As lawmakers prepare to challenge executive authority and markets brace for disruption, the outcome could redefine the U.S.’s role in the global supply chain—and the costs it’s willing to bear in pursuit of self-reliance.
Sources include: